TGFB1 and neoplasm: Additionally, they suppress anti-tumor immune responses by producing interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), inhibiting T-cell activation and promoting regulatory T-cell (Treg) recruitment (Li et al., 2023).